Vertex Pharmaceuticals Incorporated vs Stryker Corporation
Market cap comparison over time
Vertex Pharmaceuticals Incorporated
$113.0B
Rank #141
Stryker Corporation
$117.2B
Rank #136
Market Cap Over Time
Key Moments
- Stryker Corporation overtook Vertex Pharmaceuticals Incorporated by 1998
- Vertex Pharmaceuticals Incorporated overtook Stryker Corporation by 2000
- Stryker Corporation overtook Vertex Pharmaceuticals Incorporated by 2001
- Vertex Pharmaceuticals Incorporated overtook Stryker Corporation by 2015
- Stryker Corporation overtook Vertex Pharmaceuticals Incorporated by 2016
Year-by-Year Comparison
| Year | Vertex Pharmaceuticals Incorporated | Stryker Corporation | Leader |
|---|---|---|---|
| 2026 | $113.0B | $117.2B | Stryker Corporation |
| 2025 | $115.1B | $134.0B | Stryker Corporation |
| 2024 | $102.2B | $136.1B | Stryker Corporation |
| 2023 | $103.3B | $112.1B | Stryker Corporation |
| 2022 | $73.3B | $90.5B | Stryker Corporation |
| 2021 | $55.7B | $97.8B | Stryker Corporation |
| 2020 | $60.0B | $88.7B | Stryker Corporation |
| 2019 | $55.6B | $75.1B | Stryker Corporation |
| 2018 | $42.1B | $55.5B | Stryker Corporation |
| 2017 | $38.0B | $54.2B | Stryker Corporation |
| 2016 | $18.7B | $41.4B | Stryker Corporation |
| 2015 | $31.9B | $31.6B | Vertex Pharmaceuticals Incorporated |
| 2014 | $30.2B | $31.6B | Stryker Corporation |
| 2013 | $18.9B | $24.8B | Stryker Corporation |
| 2012 | $10.6B | $17.8B | Stryker Corporation |
| 2011 | $8.4B | $15.9B | Stryker Corporation |
| 2010 | $8.9B | $16.9B | Stryker Corporation |
| 2009 | $10.9B | $15.7B | Stryker Corporation |
| 2008 | $7.7B | $12.3B | Stryker Corporation |
| 2007 | $5.9B | $22.9B | Stryker Corporation |
| 2006 | $9.5B | $16.8B | Stryker Corporation |
| 2005 | $7.0B | $13.5B | Stryker Corporation |
| 2004 | $2.7B | $14.7B | Stryker Corporation |
| 2003 | $2.6B | $12.9B | Stryker Corporation |
| 2002 | $4.0B | $10.2B | Stryker Corporation |
| 2001 | $6.2B | $8.8B | Stryker Corporation |
| 2000 | $18.1B | $7.6B | Vertex Pharmaceuticals Incorporated |
| 1999 | $4.4B | $5.3B | Stryker Corporation |
| 1998 | $3.8B | $4.2B | Stryker Corporation |
| 1997 | $4.2B | $2.8B | Vertex Pharmaceuticals Incorporated |
| 1996 | $5.1B | $2.2B | Vertex Pharmaceuticals Incorporated |
| 1995 | $3.4B | $2.0B | Vertex Pharmaceuticals Incorporated |
| 1994 | $1.9B | $1.4B | Vertex Pharmaceuticals Incorporated |